Pfizer scraps daily weight loss pill after liver injury in one patient

The decision to stop developing danuglipron adds to a string of setbacks in the pharmaceutical giant’s bid to win a slice of the booming market for GLP-1s.

Read Full Article

Pfizer scraps daily weight loss pill after liver injury in one patient

Related Posts

‘A monster’: ‘Narcissist’ Trump mocked by ‘Apprentice’ actor

Thousands gather for second day to view Pope Francis

Vatican keeps St. Peters open all night for public viewing of Pope Francis due to strong turnout

Anzac Day 2025: What’s open and where major ceremonies are across Australia

Asia shares trade mixed as uncertainty persists over Trump’s tariff plans

Trump’s Approval Rating Plummets With Nearly All Key Groups: Poll – Newsweek

At Trump-themed Texas burger joint, diners eating it up

Popular Stories

Every Nationwide customer who will qualify for new 100 bonus payments

Americans sour onTrumps handling of the economy, poll finds

Baghdad invites Syrian president to summit, sparking political division in Iraq

United Kingdom could be only G7 nation not to produce its own steel; Chinese owner blames Trump tariffs

US peace plan alarms allies as Trump demands Ukraine accept Russian occupation

Sign in to Rated News

Create Rated News Account

Retrieve your password

Pfizer scraps daily weight loss pill after liver injury in one patient

Related Posts

Trending Topics

Popular Stories

Sign in to Rated News

Create Rated News Account

Retrieve your password